SANDLER ALAN B. enters REVOLUTION MEDICINES, INC. with 53K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 3/26/2026ACC: 0001610717-26-000135
Officer· Chief Development Officer
Since Mar 2026
53K
Baseline shares
100% direct
53K
Direct ownership
1 position
179K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned53K
Total
53K direct53K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 53K | Direct |
| Total | 53K | 53K direct |
Derivative Holdings2
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
167.30K
Shares owned
N/A
Exercise price
58.84
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
11.70K
Shares owned
N/A
Exercise price
102.02
Expiration
—
Exercise window
—
Total
Underlying
179K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 58.84 | — | — | 167.30K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 102.02 | — | — | 11.70K | N/A |
| Total | 179K | 0.00 | ||||